Context and Objective: Bilateral adrenal vein sampling (AVS), the diagnostic standard for identifying surgically remediable aldosteronism (SRA), is commonly performed after cosyntropin stimulation (post-ACTHstim). The role of AVS without cosyntropin stimulation (pre-ACTHstim) has not been established. The selectivity index (SI), the adrenal vein (av) serum cortisol concentration divided by that in a peripheral vein, confirms av sampling. The minimally acceptable SI is controversial. The objectives of this study were to determine the role of pre-ACTHstim AVS and a predetermined SI.
| INTRODUC TI ON
Primary aldosteronism (PA), the most common cause of secondary hypertension, affects 11%-20% of patients with drug-resistant hypertension.
1,2 As compared to essential hypertension, PA is associated with approximately a two fold increase in cardiovascular events, 3, 4 suggesting that excess aldosterone may cause damage independent of the hypertension. 3, [5] [6] [7] [8] About two-thirds of SRA is caused by either unilateral functioning adrenocortical adenomas or unilateral hyperplasia, whereas bilateral hyperplasia accounts for one-third of PA. 9 Subtype differentiation of PA directs clinical management.
Bilateral adrenal vein sampling (AVS) is considered to be the best diagnostic test for SRA identification. 10, 11 However, there is no consensus as to the best AVS protocol. 12, 13 Approximately two-third of centres perform AVS following cosyntropin administration. 15 Since cosyntropin increases the blood flow into and out of the adrenal glands, AVS is technically easier and can be performed more rapidly following cosyntropin administration. However, AVS performed only after cosyntropin administration may reduce SRA yield. 16 Furthermore, there is no agreement as to the correct selectivity index (SI) (the ratio of serum cortisol concentration in the adrenal vein to the serum cortisol concentration in a peripheral vein). If the SI is too restrictive, a proportion of true positive cases that could benefit from adrenalectomy may be excluded. Conversely, the use of a too permissive threshold may compromise specificity. Correlation of different AVS protocols with biochemical cure will determine the optimum AVS protocol.
In this study, we determine the diagnostic utility of simultaneous bilateral AVS performed both without cosyntropin stimulation (preACTHstim) and following cosyntropin stimulation (post-ACTHstim)
in the same patients and use of biochemical cure as the endpoint.
Furthermore, we determine whether a lower limit pre-ACTH SI of 1.5 decreases AVS specificity.
| MATERIAL S AND ME THODS
This study was approved by the Institutional Review Board (IRB) at the University of Connecticut Health Center. We retrospectively analysed all the PA patients who underwent simultaneous bilateral AVS at our institution between 1996 and May 2018. We correlated AVS results with biochemical cure following adrenalectomy. The primary endpoint indicating successful response to adrenalectomy was biochemical cure defined as serum aldosterone concentration <250 pmol/L (9 ng/dL) and/or plasma renin activity >2 ng/mL/h while the patient was in the sitting position and taking no agents that antagonized aldosterone or its intracellular effects. The secondary endpoints indicating successful response to adrenalectomy were reduction in the number of antihypertensive medications and resolution of hypokalemia. The terms sensitivity and specificity refer to the ability to the indicated AVS result to predict the primary end point in the patients that meet all the study inclusion criteria. The diagnostic accuracy of AVS was evaluated at different SI.
| Inclusion criteria and patient population
The inclusion criteria for our study were successful simultaneous bilateral AVS both pre-and post-ACTHstim, adrenalectomy followed 
| Adrenal vein sampling protocol
Patients were prepared for adrenal vein sampling by replacing potassium so that the serum potassium concentration was >3.5 mmol/L and by decreasing diuretic therapy so that sitting PRA was <0.5 ng/ mL/h. Adrenal veins were catheterized according to the method described by Doppman 10 except that both catheters were inserted through a single femoral vein access. The location of the adrenal veins was determined fluoroscopically by gentle injection of a small amount of isotonic and nonionic contrast media, both before and after the adrenal venous sampling as well as when necessary between different sampling sequences. In some patients, it was neces- performed. Cosyntropin was administered as a bolus of 250 mcg followed immediately by a cosyntropin infusion at 5 mcg/minute, as described by Doppman.
10
For the pre-ACTHstim measurements, the AVS was considered successful if SI was >1.5. For the post-ACTHstim measurements, the AVS was considered successful if the SI was >2.
| Biochemical assays and evaluation of biochemical results
Serum aldosterone was measured at ARUP laboratories by chemilu- were correct, we evaluated the sensitivity and specificity of the predetermined SI. The SI of the same 32 patients was divided into tertiles, and the sensitivity and specificity of the SI for predicting SRA was determined at each tertile both pre-and post-ACTHstim.
Thirty-two patients had 65 pre-ACTHstim samples and 76 postACTHstim samples. For each bilateral sampling, we report the lowest SI value of the right or left adrenal veins. Chi-square test was used to determine the statistical significance of differences in specificity and sensitivity between the tertiles.
The mean LI was used to predict the response to adrenalectomy. First, the adrenal vein serum aldosterone concentration was corrected for flow and dilution by dividing the serum aldosterone concentration by the serum cortisol concentration in that same sample. This is referred to as the cortisol corrected aldosterone concen-
tration (A/C). The lateralization index (LI) was calculated by dividing the dominant A/C (D) by the nondominant A/C (ND). The mean LI
(usually of duplicate samples but sometimes additional samples had been drawn, and these were also used) was the LI used to predict response to adrenalectomy.
Prior to the initiation of this study in 1996, we decided upon the following prespecified criteria. We offered adrenalectomy to all patients with a LI > 4.0, either pre-ACTHstim or post-ACTHstim and to those patients with contralateral suppression defined as A/C of the nondominant adrenal vein (ND) < A/C of the peripheral vein (P).
| Statistical analysis
Confidence intervals were used to determine the statistical significance of proportions. Wilcoxon signed-rank test was used to compare the pre-and postadrenalectomy aldosterone to renin ratios as well as the number of blood pressure medications before and following adrenalectomy. Chi-square test was used to determine statistical significance of differences in specificity and sensitivity between the SI tertiles. P < 0.05 was considered statistically significant.
F I G U R E 1 Biochemical cure is summarized by the mean (and range) ratio of serum aldosterone concentration to plasma renin activity (PRA) before and after adrenalectomy. The mean ratio of serum aldosterone concentration (pmol/L) to PRA (ng/ mL/h) prior to adrenalectomy was 11 080 (range = 554-30 440). Postadrenalectomy the ratio decreased to 211 pmol/L/ng/mL/h (range = 2.2-1110 pmol/L/ng/mL/h). The mean decrease was 11 050 pmol/L/ng/mL/h (95% CI = 7820-14 300 pmol/L/ng/mL/h; P < 0.0001). In common units, the mean ratio of serum aldosterone concentration (ng/dL) to PRA (ng/mL/h) prior to adrenalectomy was 400 (range = 20.4-1099). Postadrenalectomy the ratio decreased to 7.6 (range = 0.08-40). The mean decrease was 399 (95% CI: 282-516; P < 0.0001)
| RE SULTS
A total of 63 patients were confirmed biochemically to have simul- We evaluated the SRA yield of the different AVS protocols. The SRA yields of the two different AVS protocols were complementary as summarized in Figure 3 . Notably, seven out of the 32 patients (22%; CI = 11-38; P < 0.01) had an LI > 4 pre-ACTHstim, but not post-ACTHstim. Therefore, 22% of the patients with biochemically confirmed SRA, were diagnosed with SRA only by simultaneous bilateral AVS performed pre-ACTHstim. Six patients had an isolated LI > 4 only post-ACTHstim, and 18 patients had a LI > 4 both preand post-ACTHstim. Figure 4A shows the LI pre-and post-ACTHstim in those seven patients who were predicted to have SRA based upon pre-ACTHstim only. Figure 4B shows the LI of the six patients with isolated LI > 4 post-ACTHstim only. There was one patient who did not have a LI > 4, but underwent adrenalectomy because of contralateral suppression (ND < P). This patient was also cured. In summary, the two AVS protocols were complementary.
We evaluated the sensitivity and specificity of the predetermined SI. The SI of the 32 patients was divided into tertiles, and the sensitivity and specificity of the SI for predicting SRA was determined at each tertile both pre-and post-ACTHstim. The results are summarized in Table 1 pre-ACTHstim SI tertiles were 1.5-2.1, 2.3-3.5 and 3.7-42. Specificity was 100% in all tertiles. Sensitivity was 50% at the lowest SI tertile, 82% at the middle SI tertile and 81% at the greatest SI tertile (P = 0.03; chi-square). Despite the relatively low overall sensitivity of the lowest SI tertile, there were four patients in the lowest SI tertile pre-ACTHstim that did not meet SRA criteria post-ACTHstim. This is a statistically significant proportion of the total group (4 out of 32; P < 0.05), and without accepting a relatively low SI (1.5-2.1) these patients would not have been predicted to have an aldosteronoma and would not have been cured by adrenalectomy. The post-ACTHstim LI tertiles were 3.2-26, 27-41 and 42-130. Specificity was 100% in all tertiles. Sensitivity was 72% at the lowest SI tertile, 92% at the middle tertile and 73% at the greatest tertile (P = ns; chi-square). In summary, the lowest SI tertile (1.5-2.1) pre-ACTHstim does not reduce the AVS specificity and may increase the SRA yield by about 14%. Finally, the tertile with the lowest SI post-ACTHstim (3.2-26) is greater than the prespecified minimum SI of 2 and does not decrease AVS specificity.
| D ISCUSS I ON
Adrenal vein sampling is considered the diagnostic standard for identifying SRA. 10, 11, 13, 17 However, the optimal protocols for performing AVS have not been determined. A majority of centres may employ cosyntropin stimulation. 15 Cosyntropin stimulation has two advantages. First, it increases blood flow into and out the adrenal glands making AVS technically less challenging. Second, in theory, it ensures constant adrenal aldosterone and cortisol production, so that catheterization can be performed sequentially making the AVS technically less challenging and quicker. Simultaneous bilateral AVS is preferred over sequential sampling based on theoretical considerations of variable hormone secretion rates that are likely to occur when sampling is done without cosyntropin stimulation. There is no agreement as which protocol will optimize patient outcome.
Doppman preferred simultaneous bilateral AVS both pre-and post-
ACTHstim, 10 whereas Young has published extensively on results using sequential AVS performed only post-ACTHstim. 18, 19 Others recommend against the use of cosyntropin stimulation. 20 Since we had performed simultaneous bilateral AVS both pre-ACTHstim and post-ACTHstim in all PA patients undergoing adrenalectomy, we In comparison to many prior studies, 12 we used a lower SI limit (1.5 pre-ACTHstim and 2.0 post-ACTHstim) to confirm adequate sampling of the adrenal veins. Since we employed a predetermined SI in all patients, then we are in a position to evaluate the performance of this relatively low SI. Based on the CV of the cortisol assay, we calculated that a SI > 1.5 is highly unlikely to be due to a laboratory artefact or variability, and likely should indicate successful cannulation and sampling of the adrenal vein. Although our laboratory used different cortisol assays over the period of the study, the CVs were similar. The specificity of AVS in the lowest SI tertile was 100 per cent, indicating that our prediction was correct.
Furthermore, the yield of SRA may be increased by using the lowest tertile of SI pre-ACTHstim, but more patients will be required to determine whether this is reproducible. In summary, the lowest SI tertile (1.5-2.1) pre-ACTH stimulation does not reduce the AVS specificity and may increase the SRA yield. Although the predetermined SI post-ACTHstim was 2.0, the lowest SI encountered was 3.2 consistent with the well-known observation that ACTHstim increases the SI. 12, 22, 23 Other studies have examined the sensitivity and specificity of different SI, but do not use surgical cure, not biochemical cure, as the outcome. 22, 23 We argue that the gold standard outcome is biochemical cure.
In contrast to current Endocrine Society Guidelines, we no longer routinely perform confirmatory testing for PA prior to AVS. We reserve confirmatory testing for cases considered clinically less obvious and elect against salt loading in patients in whom it is contraindicated. We do agree with the Endocrine Society Guidelines'
conclusions that there is no gold standard confirmatory test and that the results can be ambiguous. 13 If confirmatory testing is necessary, then there are two possible consequences of not routinely performing confirmatory testing: First, unsuccessful adrenalectomy and, second, a low SRA yield. We examined both these possibilities. We have already discussed the first consequence; adrenalectomy effected a resolution of the renin-aldosterone abnormalities in all patients (100 per cent specificity), and all SRA patients had an apparent venous/arterial aldosterone gradient greater than 4. Therefore, they met classic criteria for hormone production by a tumour. In brief, bypassing confirmatory testing did not result in unnecessary adrenalectomies.
Second, we did not have a low SRA yield. We reported 63 patients with successful simultaneous bilateral AVS, and adrenalectomy was recommended for 45 (71 per cent). This is similar to the yield of SRA in a study that performed AVS both pre-and post-ACTHstim only following confirmatory testing with a salt loading protocol. 16 Our study calls into question the utility of routine confirmatory testing.
There are a number of strengths to this study. Foremost, this is a head-to-head comparison of two different AVS protocols in the same patients that is superior to a randomized study that has been proposed by others. 12 We were able to identify clinically important differences in the performance of the two protocols with a relatively modest number of patients. A second strength is the use of strict adherence to predetermined criteria for establishing successful AVS and for predicting SRA. The third major strength of this study is the primary endpoint of biochemical cure. PA is defined by biochemical abnormalities of the renin-angiotensin-aldosterone system, and we argue that gold standard for cure should be defined by normalization of these biochemical abnormalities. In contrast, one large study defined successful adrenalectomy as the identification of an adrenal cortical adenoma without regards to biochemical cure. 19 Since the hormone production of an adrenal cortical adenoma cannot be TA B L E 1 Sensitivity and specificity of the LI in predicting SRA at each tertile of SI both pre-and post-ACTHstim determined by conventional pathology, this endpoint may be misleading. In summary, there are three strengths of this study not found in most other studies evaluating the efficacy of adrenalectomy for PA.
A potential weakness of the study is that not all patients predicted to have SRA underwent adrenalectomy and had a postadrenalectomy evaluation. Our study analysed 32 patients. This group of 32 patients came from a larger group of 45 patients who were diagnosed with SRA based upon AVS results. Seven of these patients
were excluded from our analysis because they elected against adrenalectomy, and another six were excluded because they did not return for follow-up biochemical testing following adrenalectomy.
However, of the 13 patients excluded, 4 (31 per cent) were predicted to have SRA based upon an isolated pre-ACTHstim LI > 4; a fraction similar to that of our study group.
We acknowledge that a potential weakness of our study is the modest number of patients. Therefore, the precise percentage of subjects identified to have SRA by pre-ACTHstim should be considered as an estimate. One patient with a LI < 4 both pre-and postACTHstim underwent adrenalectomy based upon the finding of the ND < P ratios of A/C. However, too few patients had this isolated criterion to determine its sensitivity and specificity.
In summary, performing simultaneous bilateral AVS both pre- We conclude that simultaneous bilateral AVS performed both pre-ACTHstim and post-ACTHstim maximizes SRA identification without sacrificing specificity. A minimum SI of 1.5 pre-ACTHstim does not reduce specificity.
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